Transient acute depression induced by high-frequency deep-brain stimulation

New England Journal of Medicine

Volumn 340, Issue 19, 1999, Pages 1476-1480

  Bejjani, Boulos Paul ^a,b   Damier, Philippe ^a   Arnulf, Isabelle ^a   Thivard, Lionel ^c   Bonnet, Anne Marie ^a   Dormont, Didier ^b   Cornu, Philippe ^b   Pidoux, Bernard ^b   Samson, Yves ^c   Agid, Yves ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; LORAZEPAM; PERGOLIDE;

AGED; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL FEATURE; DEPRESSION; FEMALE; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTIPARKINSON AGENTS; BRAIN; DEPRESSION; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; HUMANS; LEVODOPA; PARKINSON DISEASE; SUBSTANTIA NIGRA; THALAMIC NUCLEI;

EID: 0033551330     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199905133401905     Document Type: Article

References (24)

1. Benabid AL, Pollak P, Gervason CL, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-6.
2. Limousin P, Pollak P, Benazzouz A, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995; 345:91-5.
3. Bejjani B, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease: two targets? Neurology 1997;49:1564-9.
4. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-5.
5. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. 2nd ed. Florham Park, N.J.: MacMillan Healthcare Information, 1987:153-63.
6. Dormont D, Zerah M, Cornu P, et al. A technique of measuring the precision of an MR-guided stereotaxic installation using anatomic specimens. AJNR Am J Neuroradiol 1994;15:365-71.
7. Schaltenbrand G, Wharen W. Atlas for stereotaxy of the human brain. Stuttgart, Germany: Georg Thieme, 1977.
8. 15O and positron emission tomography. J Cereb Blood Flow Metab 1984;4:329-33.
9. Friston KJ, Holmes AP, Worsley KI, Poline JB, Frith CD, Frackowiak RSJ. Statistical parametric mapping in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210.
10. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.
11. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249: 1436-8.
12. Potter WZ, Rudorfer MV, Manji H. The pharmacologic treatment of depression. N Engl J Med 1991;325:633-42.
13. Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol 1995;65:49-60.
14. Ilinsky IA, Jouandet ML, Goldman-Rakic PS. Organization of the nigrothalamocortical system in the rhesus monkey. J Comp Neurol 1985; 236:315-30.
15. Goldman-Rakic PS, Porrino LJ. The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol 1985;242:535-60.
16. Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-7.
17. Fischer H, Andersson JL, Furmark T, Fredrikson M. Brain correlates of an unexpected panic attack: a human positron emission tomographic study. Neurosci Lett 1998;251:137-40.
18. Pardo JV, Pardo PJ, Raichle ME. Neural correlates of self-induced dysphoria. Am J Psychiatry 1993;150:713-9.
19. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: importance of location of lesion. Brain 1984;107:81-93.
20. Herrmann M, Bartels C, Schumacher M, Wallesch CW. Poststroke depression: is there a pathoanatomic correlate for depression in the postacute stage of stroke? Stroke 1995;26:850-6.
21. Zald DH, Pardo JV. Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proc Natl Acad Sci U S A 1997;94:4119-24.
22. Adolphs R, Tranel D, Damasio H, Damasio AR. Fear and the human amygdala. J Neurosci 1995;15:5879-91.
23. Bevan MD, Smith AD, Bolam JP. The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat. Neuroscience 1996;75:5-12.
24. Maguire EA, Burgess N, Donnett JG, Frackowiak RS, Frith CD, O'Keefe J. Knowing where and getting there: a human navigation network. Science 1998;280:921-4.